Status notes
BPC-157 compounding status in 2026 (facts and sources)
BPC-157 sits at the center of 2026 compounding headlines. This note sticks to dated public actions and primary links. It is not legal advice and not a medical claim.
What happened
- July 23–24, 2026 — PCAC: The Pharmacy Compounding Advisory Committee recommended adding BPC-157 (among others) to the 503A Bulks List. Votes are non-binding. FDA meeting page.
- Filed 2026-10-28 / FR publish 2026-10-30 — HHS interim policy: HHS names BPC-157 in Appendix A for interim 503A enforcement discretion under stated conditions while bulks-list rulemaking continues. HHS appendix · FR notice.
HHS materials also note Category 2 history for the six peptides into April 2026; removal from Category 2 is not the same as final bulks-list placement.
What did not happen
- FDA did not “approve BPC-157” as a finished drug through this interim policy alone.
- The policy is not, by itself, final 503A bulks-list rulemaking.
- It does not authorize 503B outsourcing facilities.
- It does not convert research-use catalogs into compounding pharmacies.
Research listing on peptide.prof
peptide.prof lists BPC-157 research vials (5 mg and 10 mg) with pack pricing. Stock follows the Lotus live inventory feed. When Lotus shows out of stock, the product page stays indexable with OutOfStock schema, and add to cart is blocked in the UI and on the order API.
Related: full tracker · compounded vs RUO · TB-500 · KPV · MOTS-c.
FAQ
- Is BPC-157 legal to buy as a research chemical?
- This page summarizes public compounding-policy documents; it is not a legality opinion for every jurisdiction or use case. peptide.prof sells BPC-157 only as laboratory research material, not for human or veterinary use.
- Does HHS enforcement discretion mean BPC-157 is FDA approved?
- No. The interim policy is not FDA approval of BPC-157 as a finished drug.
- Where can researchers see peptide.prof stock and price?
- Open the BPC-157 product page for live pack prices and stock state. Out-of-stock strengths cannot be added to cart.
Research use only. Not for human or veterinary use. No dose or administration instructions on this site. peptide.prof does not compound under section 503A or 503B.